Ben Machielse

Regulation, suspicion slow U.S. flu response: hearing

WASHINGTON (Reuters) - Vaccine makers praised the U.S. response to the swine flu pandemic on Wednesday but said regulatory delays and public suspicion have held up innovative ways to speed and stretch the U.S. influenza vaccine supply.
 

Regulation, suspicion slow U.S. flu response: hearing

WASHINGTON (Reuters) - Vaccine makers praised the U.S. response to the swine flu pandemic on Wednesday but said regulatory delays and public suspicion have held up innovative ways to speed and stretch the U.S. influenza vaccine supply.
 

US: 160M doses of swine flu vaccine due in Oct.

US says swine flu vaccine supplies still tight but maker of nasal-spray version may help. The U.S. may have as many as 160 million doses of swine flu vaccine available sometime in October, even though manufacturers worldwide are having serious trouble brewing shots, federal health officials said Thursday.
 

US: 160M doses of swine flu vaccine due in Oct.

US says swine flu vaccine supplies still tight but maker of nasal-spray version may help. The U.S. may have as many as 160 million doses of swine flu vaccine available sometime in October, even though manufacturers worldwide are having serious trouble brewing shots, federal health officials said Thursday.
 

US: 160M doses of swine flu vaccine due in Oct.

The U.S. may have as many as 160 million doses of swine flu vaccine available sometime in October, even though manufacturers worldwide are having serious trouble brewing shots, federal health officials said Thursday.
 

U.S. panel prepares to OK swine flu vaccine trials

GAITHERSBURG, Maryland (Reuters) - The U.S. Food and Drug Administration wants to help rush through approval of new vaccine to fight the pandemic H1N1 virus, promising to watch more closely than ever bad effects from the immunization, officials said on Thursday.